Kaken Pharmaceutical Co., Ltd.(KKPCF)

Research Snapshot

Kaken Pharmaceutical Co., Ltd. (KKPCF) is a Healthcare stock with a market cap of $154.31B and listed on OTC. The stock last traded around $26.00 and down 7.4% across the available one-year price window (Jun 30, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of -18.3%, EPS growth of +71.8%, a dividend yield of 4.7%. What stands out right now is revenue -18.3%, EPS +71.8%, free cash flow -165.0% with operating margin -1.2% and ROIC -2.2%. The dividend matters to the case here, with a current yield around 4.7%. Valuation is more restrained than many high-expectation growth names at price/sales 2.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines KKPCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.